Zaremba S - Search Results

1

Agonist peptide from a cytotoxic t-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide.

Salazar E, Zaremba S, Arlen PM, Tsang KY, Schlom J. Salazar E, et al. Among authors: zaremba s. Int J Cancer. 2000 Mar 15;85(6):829-38. doi: 10.1002/(sici)1097-0215(20000315)85:6<829::aid-ijc16>3.0.co;2-k. Int J Cancer. 2000. PMID: 10709104 Free article.

2

Strategies in the development of recombinant vaccines for colon cancer.

Schlom J, Tsang KY, Kantor JA, Abrams SI, Zaremba S, Greiner J, Hodge JW. Schlom J, et al. Among authors: zaremba s. Semin Oncol. 1999 Dec;26(6):672-82. Semin Oncol. 1999. PMID: 10606260 Review.

3

Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.

Tsang KY, Zhu M, Nieroda CA, Correale P, Zaremba S, Hamilton JM, Cole D, Lam C, Schlom J. Tsang KY, et al. Among authors: zaremba s. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2439-49. Clin Cancer Res. 1997. PMID: 9815645

4

Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide.

Correale P, Walmsley K, Zaremba S, Zhu M, Schlom J, Tsang KY. Correale P, et al. Among authors: zaremba s. J Immunol. 1998 Sep 15;161(6):3186-94. J Immunol. 1998. PMID: 9743387 Free article.

5

Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.

Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J. Zaremba S, et al. Cancer Res. 1997 Oct 15;57(20):4570-7. Cancer Res. 1997. PMID: 9377571

6

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen.

Correale P, Walmsley K, Nieroda C, Zaremba S, Zhu M, Schlom J, Tsang KY. Correale P, et al. Among authors: zaremba s. J Natl Cancer Inst. 1997 Feb 19;89(4):293-300. doi: 10.1093/jnci/89.4.293. J Natl Cancer Inst. 1997. PMID: 9048833

7

Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.

Abrams SI, Stanziale SF, Lunin SD, Zaremba S, Schlom J. Abrams SI, et al. Among authors: zaremba s. Eur J Immunol. 1996 Feb;26(2):435-43. doi: 10.1002/eji.1830260225. Eur J Immunol. 1996. PMID: 8617315

8

Biologic properties of a CH2 domain-deleted recombinant immunoglobulin.

Slavin-Chiorini DC, Horan Hand PH, Kashmiri SV, Calvo B, Zaremba S, Schlom J. Slavin-Chiorini DC, et al. Among authors: zaremba s. Int J Cancer. 1993 Jan 2;53(1):97-103. doi: 10.1002/ijc.2910530119. Int J Cancer. 1993. PMID: 8416208

9

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine.

Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J. Tsang KY, et al. Among authors: zaremba s. J Natl Cancer Inst. 1995 Jul 5;87(13):982-90. doi: 10.1093/jnci/87.13.982. J Natl Cancer Inst. 1995. PMID: 7629885

10

Construction and purification of domain-deleted immunoglobulin variants of the recombinant/chimeric B72.3 (y1) monoclonal antibody.

Calvo B, Kashmiri SV, Hutzell P, Hand PH, Slavin-Chiorini DC, Schlom J, Zaremba S. Calvo B, et al. Among authors: zaremba s. Cancer Biother. 1993 Spring;8(1):95-109. doi: 10.1089/cbr.1993.8.95. Cancer Biother. 1993. PMID: 7529083

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results